Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Predictive Autoantibody Signature in Multiple Sclerosis. | medRxiv | 2023 | 37205595 | PubTator, text mining | PubMed |
| Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase. | Cancer Cell Int | 2023 | 37198667 | PubTator, text mining | PubMed |
| Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology. | J Adv Pract Oncol | 2023 | 37197733 | PubTator, text mining | PubMed |
| Pyruvate Kinase Deficiency Causing Priapism. | Case Rep Hematol | 2023 | 37197195 | PubTator, text mining | PubMed |
| Deep sampling of gRNA in the human genome and deep-learning-informed prediction of gRNA activities. | Cell Discov | 2023 | 37193681 | PubTator, text mining | PubMed |
| Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer. | Cancers (Basel) | 2023 | 37190124 | PubTator, text mining | PubMed |
| Specific correction of pyruvate kinase deficiency-causing point mutations by CRISPR/Cas9 and single-stranded oligodeoxynucleotides. | Front Genome Ed | 2023 | 37188156 | PubTator, text mining | PubMed |
Detection of pathogens and antimicrobial resistance genes directly from urine samples in patients suspected of urinary tract infection by metagenomics nanopore sequencing: A large-scale multi-centre study. | Clin Transl Med | 2023 | 37186513 | PubTator, text mining | PubMed |
| ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 37181232 | PubTator, text mining | PubMed |
| Bioinformatics identification of prognostic genes and potential interaction analysis in renal cell carcinoma. | Transl Cancer Res | 2023 | 37180655 | PubTator, text mining | PubMed |
| Improving the Surface Integrity of 316L Steel in the Context of Bioimplant Applications. | Materials (Basel) | 2023 | 37176341 | PubTator, text mining | PubMed |
PYK-SubstitutionOME: an integrated database containing allosteric coupling, ligand affinity and mutational, structural, pathological, bioinformatic and computational information about pyruvate kinase isozymes. | Database (Oxford) | 2023 | 37171062 | PubTator, text mining | PubMed |
| The role of noncoding RNAs in metabolic reprogramming of cancer cells. | Cell Mol Biol Lett | 2023 | 37161350 | PubTator, text mining | PubMed |
| Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade. | J Immunother Cancer | 2023 | 37156551 | PubTator, text mining | PubMed |
| The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways. | Microbiol Spectr | 2023 | 37154717 | PubTator, text mining | PubMed |
| Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K/AKT/GSK-3β Pathway. | Appl Biochem Biotechnol | 2023 | 37129745 | PubTator, text mining | PubMed |
| Age-related telomere attrition in the human putamen. | Aging Cell | 2023 | 37129365 | PubTator, text mining | PubMed |
| CD36 regulates diurnal glucose metabolism and hepatic clock to maintain glucose homeostasis in mice. | iScience | 2023 | 37123238 | PubTator, text mining | PubMed |
| PK1 from Drosophila obscurin is an inactive pseudokinase with scaffolding properties. | Open Biol | 2023 | 37121260 | PubTator, text mining | PubMed |
| Enhancement of hMSC In Vitro Proliferation by Surface Immobilization of a Heparin-Binding Peptide. | Molecules | 2023 | 37110656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers?page=13